Economic Benefits of Digital Bioprocess Development
Advanced digital technologies stand ready to slash manufacturing cost of goods sold while reducing costs in process development
Digital transformation is reshaping biopharmaceutical process development, which has traditionally been a time-intensive and costly endeavor. Significant financial and operational benefits are emerging as the industry pivots from classical methods to innovative digital strategies.
Advanced digital tools and approaches, including quality-by-design, hybrid modeling, transfer learning, and digital twins, not only enhance efficiency in process development but also substantially cut manufacturing costs—achieving up to a 70% reduction in the cost of goods sold.
In a new Pharma’s Almanac article, Fabian Feidl, Co-Founder and Chief Technology Officer of DataHow, shares an adaptation of his MBA thesis. In this article, Fabian discusses:
- Sources of costs and pricing pressures challenging the industry
- The financial returns, across development and manufacturing, from implementing digital process development
- Strategies and considerations when implementing digital process development
